GLP-1 clinical trials in Nevada: 11 recruiting now

18 sites in 3 Nevada cities. Registry checked October 16, 2026.

Screening for a study can take weeks. Two cash programs to check.

No insurance needed.

  1. SnagRx$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
  2. Medvi$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up

Weight-loss studies (3)

Weight-loss study of maridebart cafraglutide

Where: Las Vegas

What: Tests whether a study medicine from Amgen, Maridebart Cafraglutide, can help people lose weight.

Free to join

Who can join: Adults 18+ with obesity or overweight, BMI 25+.

Study record on ClinicalTrials.gov

Excel Clinical Research, Las Vegas

Weight-loss study of semaglutide

Where: Las Vegas

What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people lose weight.

Free to join

Who can join: Adults 18+ who are overweight, BMI 27+.

Study record on ClinicalTrials.gov

Jubilee Clinical Research, Inc., Las Vegas

Type 2 diabetes studies (3)

Type 2 diabetes study of semaglutide

Where: Henderson and Las Vegas

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Study record on ClinicalTrials.gov

Research Site, Henderson

Research Site, Las Vegas

Type 2 diabetes study of cagrisema

Where: Las Vegas

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 25+.

Study record on ClinicalTrials.gov

Palm Research Center Inc-Vegas, Las Vegas

Type 2 diabetes study of icovamenib

Where: Las Vegas

What: Tests whether an investigational medicine from Biomea Fusion, icovamenib, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18 to 70 with type 2 diabetes, BMI 25+.

Study record on ClinicalTrials.gov

Excel Clinical Research, Las Vegas

Other GLP-1 studies in Nevada (5)

Fatty liver disease with liver scarring study of survodutide

Where: Las Vegas

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Clinical Research of South Nevada, Las Vegas. 833-602-2368

Excel Clinical Research, Las Vegas. 833-602-2368

Jubilee Clinical Research, Inc, Las Vegas. 833-602-2368

Fatty liver disease (also called MASH or NASH) study of survodutide

Where: Las Vegas

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Clinical Research of South Nevada, Las Vegas. 833-602-2368

Excel Clinical Research, Las Vegas. 833-602-2368

Jubilee Clinical Research, Inc, Las Vegas. 833-602-2368

Fatty liver disease (MASLD) study of retatrutide

Where: Las Vegas

What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.

Call the site: 702-680-1500Study record on ClinicalTrials.gov

Excel Clinical Research, LLC, Las Vegas. 702-680-1500

Jubilee Clinical Research NV. LLC, Las Vegas. 702-631-5000

Show 2 more studies

Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.